Generation Bio Net Profit Margin 2020-2023 | GBIO
Generation Bio net profit margin from 2020 to 2023. Net profit margin can be defined as net Income as a portion of total sales revenue.
| Generation Bio Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Generic Drugs | $0.211B | $0.006B |
| Generation Bio Co. is a genetic medicines company. It is focused on creating gene therapy for patients suffering from both rare and prevalent diseases. Generation Bio Co. is based in CAMBRIDGE, Mass. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | Israel | $15.673B | 5.66 |
| Dr Reddy's Laboratories (RDY) | India | $12.551B | 19.84 |
| Aspen Pharmacare (APNHY) | South Africa | $5.574B | 0.00 |
| BridgeBio Pharma (BBIO) | United States | $5.208B | 0.00 |
| Bausch Health Cos (BHC) | Canada | $2.868B | 2.18 |
| Amphastar Pharmaceuticals (AMPH) | United States | $2.042B | 14.20 |
| Supernus Pharmaceuticals (SUPN) | United States | $1.695B | 0.00 |
| Taysha Gene Therapies (TSHA) | United States | $0.481B | 0.00 |
| Personalis (PSNL) | United States | $0.078B | 0.00 |
| Assembly Biosciences (ASMB) | United States | $0.072B | 0.00 |
| Acasti Pharma (ACST) | Canada | $0.028B | 0.00 |
| Sol-Gel Technologies (SLGL) | Israel | $0.024B | 0.00 |
| Evoke Pharma (EVOK) | United States | $0.004B | 0.00 |
| Teligent (TLGT) | United States | $0.000B | 0.00 |